{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:57:06Z","timestamp":1790009826161,"version":"4.0.1"},"reference-count":14,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,9,1]]},"DOI":"10.1093\/jac\/dki268","type":"journal-article","created":{"date-parts":[[2005,7,26]],"date-time":"2005-07-26T22:33:27Z","timestamp":1122417207000},"page":"590-593","source":"Crossref","is-referenced-by-count":31,"title":["Activity of aminocandin (IP960) compared with amphotericin B and fluconazole in a neutropenic murine model of disseminated infection caused by a fluconazole-resistant strain of Candida tropicalis"],"prefix":"10.1093","volume":"56","author":[{"given":"Peter A.","family":"Warn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Sharp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham","family":"Morrissey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Denning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2005,6,30]]},"reference":[{"key":"key\n\t\t\t\t20171012184734_B1","doi-asserted-by":"crossref","unstructured":"Andes D, Marchillo K, Lowther J et al. In vivo pharmacodynamics of HMR 3270, a glucan synthase inhibitor, in a murine candidiasis model. Antimicrob Agents Chemother2003; 47: 1187\u201392.","DOI":"10.1128\/AAC.47.4.1187-1192.2003"},{"key":"key\n\t\t\t\t20171012184734_B2","unstructured":"Warn P, Sharp A, Morrissey G et al. The in vivo activity of HMR3270 in a neutropenic murine model of disseminated infection caused by Candida tropicalis. In: Abstracts of the Forty-first Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL, 2001. Abstract J-1617, p. 391. American Society for Microbiology, Washington, DC, USA."},{"key":"key\n\t\t\t\t20171012184734_B3","unstructured":"Moore CB, Denning DW. In vitro activity of HMR3270 against Candida spp. In: Abstracts of the Forty-first Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL, 2001. Abstract F-2147, p. 252. American Society for Microbiology, Washington, DC, USA."},{"key":"key\n\t\t\t\t20171012184734_B4","unstructured":"Dromer F, Abdoul L, Improvisi L. In vitro activity of HMR 3270 against yeasts and filamentous fungi. In: Abstracts of the Forty-first Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL, 2001. Abstract F-2148, p. 252. American Society for Microbiology, Washington, DC, USA."},{"key":"key\n\t\t\t\t20171012184734_B5","doi-asserted-by":"crossref","unstructured":"Ullmann AJ. Review of the safety, tolerability, and drug interactions of the new antifungal agents caspofungin and voriconazole. Curr Med Res Opin2003; 19: 263\u201371.","DOI":"10.1185\/030079903125001884"},{"key":"key\n\t\t\t\t20171012184734_B6","doi-asserted-by":"crossref","unstructured":"Denning DW. Echinocandin antifungal drugs. Lancet2003; 362: 1142\u201351.","DOI":"10.1016\/S0140-6736(03)14472-8"},{"key":"key\n\t\t\t\t20171012184734_B7","doi-asserted-by":"crossref","unstructured":"Warn PA, Morrissey J, Moore CB et al. In vivo activity of amphotericin B lipid complex in immunocompromised mice against fluconazole-resistant or fluconazole-susceptible Candida tropicalis. Antimicrob Agents Chemother2000; 44: 2664\u201371.","DOI":"10.1128\/AAC.44.10.2664-2671.2000"},{"key":"key\n\t\t\t\t20171012184734_B8","doi-asserted-by":"crossref","unstructured":"Cuenca-Estrella M, Moore CB, Barchiesi F et al. Multicenter evaluation of the reproducibility of the proposed antifungal susceptibility testing method for fermentative yeasts of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibility Testing (AFST-EUCAST). Clin Microbiol Infect2003; 9: 467\u201374.","DOI":"10.1046\/j.1469-0691.2003.00592.x"},{"key":"key\n\t\t\t\t20171012184734_B9","doi-asserted-by":"crossref","unstructured":"Cuenca-Estrella M, Lee-Yang W, Ciblak MA et al. Comparative evaluation of NCCLS M27-A and EUCAST broth microdilution procedures for antifungal susceptibility testing of Candida species. Antimicrob Agents Chemother2002; 46: 3644\u20137.","DOI":"10.1128\/AAC.46.11.3644-3647.2002"},{"key":"key\n\t\t\t\t20171012184734_B10","doi-asserted-by":"crossref","unstructured":"Warn PA, Sharp A, Guinea J et al. Effect of hypoxic conditions on in vitro susceptibility testing of amphotericin B, itraconazole and micafungin against Aspergillus and Candida. JAntimicrob Chemother2004; 53: 743\u20139.","DOI":"10.1093\/jac\/dkh153"},{"key":"key\n\t\t\t\t20171012184734_B11","doi-asserted-by":"crossref","unstructured":"Denning DW, Hall L, Jackson M et al. Efficacy of D0870 compared with those of itraconazole and amphotericin B in two murine models of invasive aspergillosis. Antimicrob Agents Chemother1995; 39: 1809\u201314.","DOI":"10.1128\/AAC.39.8.1809"},{"key":"key\n\t\t\t\t20171012184734_B12","doi-asserted-by":"crossref","unstructured":"Warn PA, Sharp A, Morrissey G et al. In vivo activity of micafungin in a persistently neutropenic murine model of disseminated infection caused by Candida tropicalis. J Antimicrob Chemother2002; 50: 1071\u20134.","DOI":"10.1093\/jac\/dkf247"},{"key":"key\n\t\t\t\t20171012184734_B13","unstructured":"Conover WJ. Practical Nonparametric Statistics, 3rd edn. New York, USA: Wiley, 1999."},{"key":"key\n\t\t\t\t20171012184734_B14","unstructured":"Indevus press release, 9 June 2004. Indevus announces favourable results of Phase I clinical trial of aminocandin for systemic fungal infections. http:\/\/www.Indevus.com (25 August 2004, date last accessed)."}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/56\/3\/590\/2030147\/dki268.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,10,12]],"date-time":"2017-10-12T19:31:53Z","timestamp":1507836713000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/jac\/article\/56\/3\/590\/691073\/Activity-of-aminocandin-IP960-compared-with"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6,30]]},"references-count":14,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2005,6,30]]},"published-print":{"date-parts":[[2005,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dki268","relation":{},"ISSN":["1460-2091","0305-7453"],"issn-type":[{"value":"1460-2091","type":"electronic"},{"value":"0305-7453","type":"print"}],"subject":[],"published-other":{"date-parts":[[2005,9]]},"published":{"date-parts":[[2005,6,30]]}}}